Awareness of Dysphagia-Related Complications and Risks and the Importance of Early Intervention in Patients with Parkinson’s Disease: A Qualitative Study

Table 1

Basic information of the interviewee.

Code	Gender	Age	Occupation	Educational background	Payment method	Course of disease	Staging of H-Y	UPDRS part II salivation score	Types of anti-Parkinsondrugs
N1	Female	77	Retired	University	Medical insurance	2.5	1	1	1.2.3
N2	Female	43	Supermarket clerk	Middle school	Medical insurance	2	2	1	1.2.3
N3	Female	56	Retired	Middle school	Medical insurance	2	1	1	1.2.3
N4	Male	45	Agency	University	Medical insurance	1	1	1	1.3
N5	Male	52	Driver	Middle school	Medical insurance	2	1	1	1.2.3
N6	Female	72	Farmer	Illiterate	Self-paid	10	2	2	1.2.3.5
N7	Male	75	Cashier	Primary school	Self-paid	17	2	1	1.2.3.5
N8	Male	67	Retired	Middle school	Medical insurance	4	1	3	1.3
N9	Male	76	Buddhist monk	Senior high school	Self-paid	6	2	1	1.2.3
N10	Female	74	Farmer	Primary school	Self-paid	12	1	1	1.2.3.5
N11	Male	80	Unemployed	Illiteracy	Self-paid	15	2	3	1.2.3.5
N12	Male	58	Businessman	Middle school	Medical insurance	3	1	1	1.3
N13	Male	49	Retired	Middle school	Medical insurance	1	2	1	2
N14	Female	68	Unemployed	Middle school	Self-paid	3	2	1	2
N15	Male	75	Veteran	University	Medical insurance	5	1	2	1.2.3
N16	Male	78	Unemployed	Primary school	Self-paid	8	1	1	1.2.3
N17	Female	74	Retired	Middle school	Medical insurance	6	1	1	1.2.3
N18	Male	72	Retired	Primary school	Medical insurance	8	1	1	1.2.3

Note. Types of anti-Parkinson drugs: 1. Anticholinergics; 2. Amantadine; 3. Dopamine; 4. DR agonist; 5. Monoamine oxidase-B inhibitors; 6. COMT inhibitors.